Skip to main content
Clinical Trials/IRCT20170513033941N29
IRCT20170513033941N29
Completed
Phase 2

Clinical trial of the effect of melatonin supplementation compared with the placebo on clinical status, metabolic profiles and gene expression related to inflammation, insulin and lipid in patients with Parkinson's disease

Kashan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Kashan University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with Parkinson' disease.
  • Individuals aged 50 to 90 years.

Exclusion Criteria

  • Unwillingness to cooperate

Outcomes

Primary Outcomes

Not specified

Similar Trials